Showing results (241-250 of 465) with videos related to
Sort By:
Pageof 47
British Journal of Cancer|October 14, 2005
Endothelial apoptotic activity of angiocidin is dependent on its polyubiquitin binding activityS Dimitrov, Y Sabherwal, D D Raymond, et al.Molecular Pharmaceutics|April 17, 2023
Human Antibody VH Domains Targeting GPNMB and VCAM-1 as Candidate Therapeutics for CancersXiaojie Chu, Wei Li, Margaret G Hines, et al.Free Radical Research|November 27, 2014
Ankyrin is the major oxidised protein in erythrocyte membranes from end-stage renal disease patients on chronic haemodialysis and oxidation is decreased by dialysis and vitamin C supplementationT Ruskovska, S J Bennett, C R Brown, et al.Journal of Molecular Biology|January 24, 2006
Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifsPonraj Prabakaran, Jianhua Gan, You-Qiang Wu, et al.Mabs|December 5, 2019
An engineered human IgG1 CH2 domain with decreased aggregation and nonspecific bindingGuangcan Cao, Xinyu Gao, Yancheng Zhan, et al.Journal of Virology|September 15, 2005
Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tailStéphanie Wyss, Antony S Dimitrov, Frédéric Baribaud, et al.Molecular Pharmaceutics|May 7, 2013
N-terminal truncation of an isolated human IgG1 CH2 domain significantly increases its stability and aggregation resistanceRui Gong, Yanping Wang, Tianlei Ying, et al.Diagnostic Microbiology and Infectious Disease|October 13, 2007
Emergence of multidrug-resistant Salmonella spp. and isolates with reduced susceptibility to ciprofloxacin in Kuwait and the United Arab EmiratesVincent O Rotimi, Wafaa Jamal, Tibor Pal, et al.Molecular Cancer Therapeutics|May 7, 2009
A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicityYang Feng, Xiaodong Xiao, Zhongyu Zhu, et al.Journal of Virology|June 28, 2003
Multiple interactions across the surface of the gp120 core structure determine the global neutralization resistance phenotype of human immunodeficiency virus type 1Peter Bouma, Maria Leavitt, Peng Fei Zhang, et al.Pageof 47